Hearne Michael S — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Hearne Michael S has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Profile

Michael S. Hearne is identified in SEC filings as the Chief Financial Officer of Aurinia Pharmaceuticals Inc. as of May 20, 2026. The context provided only confirms his role and affiliation with Aurinia; additional biographical details are not included in the SEC context provided.

Board memberships

• Aurinia Pharmaceuticals Inc.

Awards & honors

• Named Chief Financial Officer of Aurinia Pharmaceuticals Inc. per SEC filings dated on or before 2026-05-20.

Recent Transactions

Companies — Last 90 Days

• Aurinia Pharmaceuticals Inc. (AUPH) — 1 filings, last 2026-05-20

Frequently Asked Questions

Who is Hearne Michael S?

Michael S. Hearne is identified in SEC filings as the Chief Financial Officer of Aurinia Pharmaceuticals Inc. as of May 20, 2026. The context provided only confirms his role and affiliation with Aurinia; additional biographical details are not included in the SEC context provided.…

How many SEC Form 4 filings has Hearne Michael S submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Hearne Michael S's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week